Qiagen Investors Shun Thermo Fisher's $12.5B Offer
Thermo Fisher Scientific's $12.5 billion attempted takeover of European genetic testing company Qiagen fell apart Thursday, after the sweetened proposal failed to win over a majority of Qiagen's shareholders....To view the full article, register now.
Already a subscriber? Click here to view full article